Similarly, examining the interaction with HSA is essential for assessing the stability and bioavailability of Ru(II) complexes in therapeutic applications, especially in cancer treatment, and conformational changes in the albumins caused by interaction with complexes which can provide clues about the mechanism of action and the effectiveness of these complexes. The gene discussed is ALB; the disease is cancer.